Search Results
Test Catalog
SDEX - Overview: Sickle Solubility, Blood
Screening for presence or absence of hemoglobin (Hb) S (sickle cell disease)
SP7TC - Overview: Septin-7 Antibody, Tissue Immunofluorescence Titer, Spinal Fluid
Detecting septin-7 IgG in cerebrospinal fluid (CSF) specimens Reporting an end titer result from CSF specimens
SP5TS - Overview: Septin-5 Antibody, Tissue Immunofluorescence Titer, Serum
Detecting septin-5 IgG in serum specimens Reporting an end titer result from serum specimens
SP5TC - Overview: Septin-5 Antibody, Tissue Immunofluorescence, Spinal Fluid
Detecting septin-5 IgG in spinal fluid (CSF) specimens Reporting an end titer result from CSF specimens
DESPR - Overview: Desipramine, Serum
Monitoring serum concentration of desipramine during therapy Evaluating potential desipramine toxicity May aid in evaluating patient compliance
DCTR - Overview: Direct Antiglobulin Test (Polyspecific), Blood
Demonstrating in vivo coating of red blood cells with IgG or the complement component C3d in the following settings: -Autoimmune hemolytic anemia -Hemolytic transfusion reactions -Drug-induced hemolytic anemia
CHOL - Overview: Cholesterol, Total, Serum
Evaluation of cardiovascular risk
DSAC - Overview: Disaccharidase Activity Panel, Tissue
Evaluation of patients who present with signs or symptoms suggestive of disaccharidase disorders This test is not intended for carrier detection.
DEXA - Overview: Dexamethasone, Serum
Confirming the presence of dexamethasone in serum Confirming the cause of secondary adrenal insufficiency This test is not useful as the sole basis for a diagnosis or treatment decisions.
DLAU - Overview: D-Lactate, Urine
Preferred test for diagnosing D-lactate acidosis, especially in patients with jejunoileal bypass and short-bowel syndrome
PDSU - Overview: Drug Screen, Prescription/Over the Counter, Random, Urine
Qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent Providing, when possible, the identification of all drugs in the specimen This test is not...
DLAC - Overview: D-Lactate, Plasma
As an adjunct to urine D-lactate (preferred) for the diagnosis of D-lactate acidosis
Diagnosis of small cell lung carcinoma (SCLC), large cell neuroendocrine carcinoma (LCNEC), amongst other tumors
DIPGS - Overview: Diphtheria Toxoid IgG Antibody, Serum
Determining a patient's immunological response to diphtheria toxoid vaccination Aiding in the evaluation of immunodeficiency
EVROL - Overview: Everolimus, Blood
Managing everolimus immunosuppression in solid organ transplant
CL_F - Overview: Chloride, Feces
Workup of cases of chronic diarrhea Evaluation of suspected chloridorrhea
CITR2 - Overview: Citrate Concentration, Random, Urine
Diagnosing risk factors for patients with calcium kidney stones Monitoring results of therapy in patients with calcium stones or renal tubular acidosis
Interpretation for CIDP / Chronic Inflammatory Demyelinating Polyradiculoneuropathy/Nodopathy Evaluation, Serum
DXPIN - Overview: Doxepin and Nordoxepin, Serum
Monitoring doxepin therapy Evaluating potential doxepin toxicity Evaluating patient compliance
DULOX - Overview: Duloxetine, Serum
Monitoring duloxetine serum concentration during therapy Evaluating potential duloxetine toxicity Evaluating patient compliance
ETGC - Overview: Ethyl Glucuronide Confirmation, Random, Urine
Monitoring abstinence in clinical and justice system settings
CLDL1 - Overview: Cholesterol, Low-Density Lipoprotein (LDL), Calculated, Serum
Calculation of low-density lipoprotein cholesterol using total cholesterol, non-high-density lipoprotein (HDL) cholesterol, HDL cholesterol, and triglyceride concentrations Managing atherosclerotic cardiovascular disease risk
CCTR - Overview: Calcium/Creatinine Ratio, Random, Urine
Calculation of calcium concentration per creatinine concentration
CRETR - Overview: Creatinine, Random, Urine
Normalization of urinary analytes to account for the variation in urinary concentrations between individuals when using random urine collections
EHOLG - Overview: Entamoeba histolytica Antibody, Serum
As an adjunct in the diagnosis of extraintestinal, invasive amebiasis
EMAT - Overview: Endomysial Antibodies, IgA, Titer, Serum
Confirmation of a positive IgA-endomysial antibodies result
FXIII - Overview: Factor XIII (13), Screen, Plasma
Screening for factor XIII deficiency
5BETH - Overview: Factor V Bethesda Units, Plasma
Detecting and quantifying the presence and titer of a specific factor inhibitor directed against coagulation factor V
FLEC - Overview: Flecainide, Serum
Optimizing flecainide dosage Assessing flecainide toxicity Monitoring compliance
AFOLR - Overview: Folate Receptor Alpha (FOLR1), Semi-Quantitative Immunohistochemistry, Manual
Diagnosis of epithelial ovarian cancer that may be eligible for treatment with an anti-folate receptor 1 protein antibody
F2_IS - Overview: Factor II Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor II
11_IS - Overview: Factor XI Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor XI
F9_IS - Overview: Factor IX Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor IX
10_IS - Overview: Factor X Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor X
F7_IS - Overview: Factor VII Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor VII
F5_IS - Overview: Factor V Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor V
FL - Overview: Fluoride, Plasma
Assessing accidental fluoride ingestion Monitoring patients receiving sodium fluoride for bone disease or patients receiving voriconazole therapy
FRUCT - Overview: Fructosamine, Serum
Monitoring intermediate (1-3 weeks) glycemic control Monitoring glycemic control in patients with shortened red blood cell survival
FELBA - Overview: Felbamate (Felbatol), Serum
Determining whether a poor therapeutic response is attributable to noncompliance or lack of drug effectiveness Monitoring changes in serum concentrations resulting from interactions with coadministered drugs such as barbiturates and...
FENS - Overview: Fentanyl Screen, Random, Urine
Screening for drug abuse or use involving fentanyl
MSFGN - Overview: Fibrillary Glomerulonephritis Confirmation, Mass Spectrometry, Paraffin Tissue
Diagnosing fibrillary glomerulonephritis
FLUOX - Overview: Fluoxetine, Serum
Monitoring serum concentration of fluoxetine during therapy Evaluating potential toxicity Evaluating patient compliance
NEFA - Overview: Free Fatty Acids, Total, Serum
Evaluation of metabolic status of patients with endocrinopathies Monitoring of control of diabetes mellitus Monitoring the effects of therapeutic diet/exercise lifestyle changes
FIBAG - Overview: Fibrinogen Antigen, Plasma
Evaluation of fibrinogen deficiency Measuring fibrinogen in patients with elevated plasma levels of fibrin degradation products, patients receiving heparin, and in patients with antibodies to thrombin (following surgical use of topical...
GBETH - Overview: General Factor Bethesda Units, Plasma
Detecting and quantifying the presence and titer of a specific factor inhibitor directed against a specific coagulation factor
GPI1 - Overview: Glucose Phosphate Isomerase Enzyme Activity, Blood
The evaluation of individuals with Coombs-negative chronic hemolysis
GD65C - Overview: Glutamic Acid Decarboxylase (GAD65) Antibody Assay, Spinal Fluid
Possible use in evaluating patients with autoimmune encephalitis, stiff-person syndrome, autoimmune ataxia, autoimmune epilepsy, and other acquired central nervous system disorders affecting gabaminergic neurotransmission
GPIC - Overview: Glucose Phosphate Isomerase Enzyme Activity, Blood
The evaluation of individuals with Coombs-negative chronic hemolysis
Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with neuroendocrine tumors of the pancreas or gastrointestinal tract including metastases
KIBM - Overview: Ki-67(MIB-1), Breast, Semi-Quantitative Immunohistochemistry, Manual
Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with breast carcinoma
Site Search
Problem-Solving Thinking: An Overview of DMAIC, A3, and PDSA - Insights
PACE/State of FL - What problem-solving thinking is, as well as an overview of what DMAIC, A3, and PDSA problem-solving approaches are to support your quality and continuous improvement journey....
MayoLINK Overview Video - Mayo Clinic Laboratories
MayoLINK Overview Video - Mayo Clinic Laboratories Share Print
FISH probe & panel project: An overview - Insights
In this month's "Hot Topic," Jess Peterson, M.D., discusses changes to Mayo Clinic Laboratories’ hematology FISH menu to increase awareness, provide reasoning, and highlight some of the great things that are coming.
Lab Billing, Coding, and Compliance: A 2025 Overview - Insights
PACE/State of FL - Critical topics essential for laboratory billing, coding, and compliance.
MGLE - Overview: Myasthenia Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation, Serum
Confirming the autoimmune basis of a defect in neuromuscular transmission (eg, myasthenia gravis [MG], Lambert-Eaton myasthenic syndrome [LEMS]) Distinguishing LEMS from autoimmune forms of MG Providing a quantitative autoantibody...